Omnix Medical is developing new antimicrobial agents to fight resistant bacteria and to win the battle against Antibiotic Resistance. Bringing a new strategy against resistant bacteria Omnix is developing the next generation of antibiotic drugs. https://www.omnixmedical.com |
Eximore is developing ophthalmic drug delivery products. The company’s initial development is a non-invasive, novel sustained-release delivery system targeting glaucoma. |
TPCera develops a new type of immunomodulatory compound that shifts the immune system from an inflammatory state into an anti-inflammatory one. |